inflammatory disorders

HONG KONG, August 5, 2026 Insilico Medicine has announced the nomination of ISM9077 as its 32nd Preclinical Candidate (PCC)...

WASHINGTON, May 27, 2026 Vanda Pharmaceuticals Inc. has announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has...